Clinical Study

18F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study

Table 1

Patients and clinicopathologic characteristics.

CaseSexAge at primary diagnosisHistologic diagnosisStage at presentation 
AJCC (2010) 
and histological features

1F68PTC 
(tall cell variant)
pT3 pN1b Mx 
R1
2F69PTC 
(tall cell variant)
pT1b pN1b Mx 
R0
3F41PTV 
(classical and follicular variant)
pT4a(m) pN1b Mx 
EC R2
4F63PTC 
(classical variant)
pT3(m) pN1b Mx 
R0
5M62PTC 
(classical variant)
pT4a pN1a Mx 
R0
6M40PTC 
(classical variant)
pT3 pN1b Mx 
R0
7F74PTC 
(classical variant)
pT4a pN1a Mx 
V1 R2
8M65Follicular 
Hürthle cell carcinoma
pT4a Nx Mx 
R0
9F72PTC 
(tall cell variant)
pT3 pN1a Mx 
R1
10F81Widely invasive FTC 
(classical variant)
pT3 Nx Mx 
R1
11M63PTC 
(classical variant)
pT1a(m) pN1b Mx 
EC R0
12M65PTC 
(classical variant)
pT3 pN1b Mx 
V1 EC Rclose
13M28PTC 
(classical variant)
pT3 pN1b Mx 
R0
14M78PTC 
(classical variant)
pT3 pN1b Mx 
EC R0
15M70PTC 
(classical variant)
pT4a(m) pN1a Mx 
R2
16M75PTC 
(classical variant)
pT4a pN1b Mx 
EC R0

EC: extrathyroid extension; FTC: follicular thyroid carcinoma; G2: moderately differentiated; G3: poorly differentiated; m: multifocal; PTC: papillary thyroid carcinoma; R1: microscopic residual disease; R2: macroscopic residual disease; V1: blood vessel invasion.